Sort
40,608 grants matching “prostate cancer”
Molecularly Engineered Constructs for anti-CD20 Directed Therapeutics
$329,558Andrew A. Raubitschek · Beckman Research Institute/City Of Hope · P50 · FY2007 · CA
Novel focused ultrasound enhanced calreticulin-nanoparticle for immune primed melanoma immunotherapy
$329,555Ashish Ranjan · Oklahoma State University Stillwater · R37 · FY2021 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$329,549University Of Pittsburgh At Pittsburgh · R01 · FY2005 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$329,549University Of Pittsburgh At Pittsburgh · R01 · FY2004 · CA
Prostate Cancer Health Disparity: Role of PDEF
$329,537Hari K. Koul · Lsu Health Sciences Center · R01 · FY2023 · CA
Prostate Cancer Health Disparity: Role of PDEF
$329,537Hari K. Koul · Lsu Health Sciences Center · R01 · FY2022 · CA
Role of KLF6 Tumor Suppressor in Hepatocellular Cancer
$329,471Scott Laurence Friedman · Icahn School Of Medicine At Mount Sinai · R01 · FY2007 · DK
Project 1: Acid Ceramidase-S1P Metabolic Axis and Regulation of Tumor Resistance to Apoptosis
$329,456Christina Voelkel-Johnson · Medical University Of South Carolina · P01 · FY2020 · CA
Epithelial/stromal signaling in bladder and prostate cell proliferation
$329,437Philip A Beachy · Stanford University · R01 · FY2013 · CA
Mechanisms of Ligand-Dependent Notch Activation
$329,407Stephen C. Blacklow · Brigham And Women'S Hospital · P01 · FY2014 · CA
Chemokines, TRP Channels and Cancer Pain
$329,401Durga Prasanna Mohapatra · University Of Iowa · R01 · FY2011 · NS
Estimating the Cost Trajectories and Projecting the Cost of Cancer Care in the United States: Methodology and Application
$329,400Liang Li · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
Molecular and Cellular Mechanisms of Tumor Development
$329,397Caroline Margaret Alexander · University Of Wisconsin-Madison · T32 · FY2013 · CA
Biomarkers of Obesity, Prostate Tissue Inflammation, and BPH Progression
$329,396Jay H Fowke · Vanderbilt University · R01 · FY2013 · DK
DEVELOPMENT OF PET RADIOPHARMACEUTICALS TARGETING GRPR
$329,344Buck E Rogers · Washington University · R01 · FY2010 · CA
Initiation and Regulation of Chronic Autoimmune Prostate Inflammation
$329,320Timothy L Ratliff · Purdue University · R01 · FY2014 · DK
The function of Snf5, an epigenetic tumor suppressor
$329,307Charles W Roberts · Dana-Farber Cancer Inst · R01 · FY2006 · CA
Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ
$329,245Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL
COBRE; CREIGHTON UNIV; P10; PROSTATE CANCER: THE ROLE OF G-PROTEIN ALPHA12
$329,229Yaping Tu · University Of Nebraska Medical Center · P20 · FY2007 · RR
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$329,208Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · CA
Anticarcinogenic Effect of ITCs Against Prostate Cancer
$329,208Shivendra Singh · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · CA
PROTEIN PHOSPHATASE 2A SIGNALING IN HUMAN PROSTATE CANCER
$329,198University Of South Alabama · · FY2009 · Department of Defense
Precision Antibody Imaging & Radiotherapy of Solid Tumors
$329,195Jan E Schnitzer · Proteogenomics Research Instit/Sys/ Med · P01 · FY2022 · CA
GREATER PHOENIX COMMUNITY CLINICAL ONCOLOGY PROGRAM
$329,176Banner Good Samaritan Medical Center · U10 · FY2001 · CA
Epigenetic Alterations in Homeotic Genes
$329,175Burnham Institute For Medical Research · R01 · FY2005 · CA